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Simpler is better – the case of colorectal cancer screening 
Screening can reduce deaths from colorectal cancer but only if the people invited participate.1 The 
challenge is that high uptake is hard to achieve and this seriously limits the potential health benefit of 
screening. Within the UK, uptake of the faecal occult blood test (FOBt) has remained low and stagnant 
at around 55% since its introduction over 10 years ago.2 But, this may be set to change. Scotland 
introduced the new faecal immunochemical test (FIT) in November 2018 and uptake has risen to a 
record high of 64% within the first six months, the first time ever the uptake has exceeded the standard 
target of 60%.3 Roll out of FIT colorectal screening is planned in England and Wales in 2019. 
 
This increase in uptake of colorectal screening is impressive. Participation in screening and test kit 
return are behaviours that have been studied using theories and methods from behavioural science. 
Human behaviour is complex and often involves multiple cognitive processes that influence task 
execution, e.g. attention, memory, reflective deliberation, executive control, scheduling, routine, 
automaticity, habit etc. Behavioural science interventions in this area have often targeted 
reflective/deliberative processes. Previous attempts to improve colorectal screening uptake however, 
have been largely unsuccessful.4,5 Wardle et al.4 assessed four interventions to increase the visibility 
and salience of colorectal screening and found evidence of small increases in uptake (0.7%) with two 
of the interventions: a GP endorsed invitation letter and an enhanced reminder letter. O’Carroll et al.5 
tested the impact of asking participants to reflect on the possible consequences of non-participation, 
an anticipated regret intervention, and found no impact on uptake. These attempts, while using theory 
and evidence-based strategies, relied on written information materials to inform people about 
screening in the attempt to motivate reflection on their decision to screen. Increasingly, behavioural 
science is acknowledging that the potential for information-based interventions is fundamentally 
limited and interventions targeting environmental stimuli and cues e.g. ease of effort and product 
design may have greater potential to influence behaviour.6,7 
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The new FIT colorectal screening test is certainly a simpler and easier to use test than its FOBt 
predecessor. The new FIT requires people to collect and immediately return only one bowel motion 
instead of the six samples (two samples, stored in the home, from three separate stools) required 
previously for FOBt. Identifying the behavioural mechanisms involved in the increased uptake with the 
new FIT is vital to progress our understanding of behaviour change and improve cancer screening 
uptake. Applying the COM-B Model (‘capability’, ‘opportunity’, ‘motivation’ and ‘behaviour’8) offers 
insight into the behavioural mechanisms involved in the increased uptake with the new FIT. People’s 
capability to complete this home-based test is increased by FIT: one sample makes the test physically 
easier to complete and psychologically there are fewer cognitive demands (e.g. planning where, when, 
and how; remembering) involved than with the old FOBt. Participant’s opportunity to complete the 
new FIT is increased as one sample is easier to collect than six and is less time consuming than the old 
FOBt. People’s motivation to complete is also increased with the new FIT because important barriers 
such as disgust9 are partly overcome because only one sample is required compared to six with the 
old FOBt and there is no necessity to store the samples. Additionally, the potential social 
embarrassment barrier of the samples being found by others (e.g. grandchildren) while being stored 
in the house between samples is also reduced. 
 
The idea of simpler is better is not new, Occam’s Razor and the law of parsimony have existed for 
hundreds of years. The polypill is a good example of a simple solution to the complex problem of poor 
adherence among patients with comorbidities who require multiple medications.10 However, as we 
strive to develop new technologies and improve existing systems in cancer screening and other areas, 
simplicity of use and the importance of human factors in design need to be at the forefront of 
developers’ thoughts. The case of colorectal cancer screening illustrates that if you want to change 
behaviour to improve health, make that behaviour as simple as possible.  
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